2024-03-11 16:51:09 ET
More on Lexicon Pharmaceuticals
- Lexicon Pharmaceuticals Putting The Pieces Together, But Much Is Left To Do
- Lexicon Pharma: Inpefa's Early Clinical Benefits, Rehospitalization Data May Unlock Significant Value
- Lexicon Pharmaceuticals: Navigating The Competitive HFpEF Landscape (Rating Downgrade)
- Lexicon stock rallies 18% amid FDA update, $250M private placement
- Lexicon announces oversubscribed $250M private placement of equity securities
Read the full article on Seeking Alpha
For further details see:
Lexicon Pharmaceuticals GAAP EPS of -$0.20 in-line, revenue of $0.7M misses by $1.24M